Insulin and Glucagon Secretion during 75g OGTT before and after Liraglutide Teratment May Predict Therapeutic Response in Type2 Diabetes when Switching from Basal-Bolus Insulin Therapy to Combination of Liraglutide and Basal Insulin.

Insulin and Glucagon Secretion during 75g OGTT before and after Liraglutide Teratment May Predict Therapeutic Response in Type2 Diabetes when Switching from Basal-Bolus Insulin Therapy to Combination of Liraglutide and Basal Insulin.
复制标题

利拉鲁肽治疗前后 75g OGTT 期间的胰岛素和胰高血糖素分泌可预测 2 型糖尿病从基础推注胰岛素治疗转为利拉鲁肽和基础胰岛素联合治疗时的治疗反应。

DOI:
--
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Kawakami A.
Kawakami A.
中科院分区:
--
文献类型:
--
作者:
Horie I;Abiru N;Haraguchi A;Sako A;Niri T;Norimura A;Natsuda S;Mori Y;Ando T;Kawakami A.

文献摘要

相似文献